PALI
Palisade Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$313.45M
P/E Ratio
—
EPS
$-0.30
Beta
1.47
52W High
$2.64
52W Low
$0.53
50-Day MA
$1.79
200-Day MA
$1.48
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Palisade Bio Inc
Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company is headquartered in Carlsbad, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-18.05M |
| Operating Margin | 0.00% |
| Return on Equity | -24.50% |
| Return on Assets | -15.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.81 |
| Price-to-Book | 2.46 |
| Price-to-Sales (TTM) | 11.78 |
| EV/Revenue | 234.89 |
| EV/EBITDA | 0.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $167.42M |
| Float | $122.67M |
| % Insiders | 0.03% |
| % Institutions | 81.70% |
Analyst Ratings
Consensus ($10.75 target)
2
Strong Buy5
BuyData last updated: 4/9/2026